SCIENTIFIC PROGRAMME
| 14.30-16.00 | SO 01 PROGRESS IN BIPOLAR DISORDER |
| 14.30-14.55 | SO 0101 Treatment of mixed states Eduard VIETA (Spain) |
| 14.55-15.20 | SO 0102 Treatment of bipolar depression Alan YOUNG (United Kingdom) |
| 15.20-15.45 | SO 0103 Observational vs Randomised controlled studies Rico NIL (Switzerland) |
| 15.45-16.00 | Discussion |
| 16.00-16.30 | Coffee break |
| 16.30-18.00 | SO 02 ADVANCES IN TREATMENT OF RESISTANT DEPRESSION |
| 16.30-16.55 | SO 0201 Should we stop raising the dose in nonresponders Rasmus LICHT (Denmark) |
| 16.55-17.20 | SO 0202 Are two antidepressants better than one? Michael BAUER (Germany) |
| 17.20-17.45 | SO 0203 Pharamacogentiecs in practice: are we close? Alessandro SERRETTI (Italy) |
| 17.45-18.00 | Discussion |
| 18.00-19.00 | Opening Ceremony |
| 09.00-10.30 | SO 03 BROAD-SPECTRUM SYMPTOM CONTROL IN BIPOLAR DISORDER WHAT ARE THE CHALLENGES? Symposium sponsored by an unrestricted educational grant from H. Lundbeck A/S |
| 10.30-11.00 | Coffee break |
| 11.00-12.30 | SO 04 HOT TOPICS IN MOOD DISORDERS |
| 11.00-11.25 | SO 0401 Making sense in making guidelines Karl BROICH (Germany) |
| 11.25-11.50 | SO 0402 Educational strategies for preventing suicide: review of studies in Slovenia, Gotland and Germany Saska ROSKAR (Slovenia) |
| 11.50-12.15 | SO 0403 Why do celebrities die young? Borwin BANDELOW (Germany) |
| 12.15-12.30 | Discussion |
| 12.30-13.30 | Lunch |
| 13.30-15.00 | SO 05 OPTIMIZING TREATMENT OUTCOMES IN DEPRESSION AND ANXIETY DISORDERS Symposium sponsored by an unrestricted educational grant from H. Lundbeck A/S |
| 15.00-16.00 | SO 06 DEBATE: ANTIDEPRESSANT RESPONSE IS CLEARCUT Pro: Elias ERIKSSON (Sweden) Contra: Corrado BARBUI (Italy) |
| 16.00-16.30 | Coffee break |
| 16.30-18.00 | SO 07 NEGATIVE, COGNITIVE AND DEPRESSIVE SYMPTOMS IN SCHIZOPHRENIA |
| 16.30-16.55 | SO 0701 Depressive and negative symptoms – are they really separate? Hans-Juergen MOELLER (Germany) |
| 16.55-17.20 | SO 0702 New treatments for cognitive symptoms in schizophrenia Raimund BULLER (France) |
| 17.20-17.45 | SO 0703 Treatment of affective or negative symptoms of schizophrenia Stefan LEUCHT (Germany) |
| 17.45-18.00 | Discussion |
| 09.00-10.30 | SO 08 COGNITIVE DYSFUNCTION OF DEPRESSION A SYMPTOM THAT WE FAIL TO TREAT? |
| 09.00-09.30 | SO 0801 Current antidepressant treatments: what do we have and what do we need? Philip COWEN (United Kingdom) |
| 09.30-10.00 | SO 0802 Assessing cognitive dysfunction in the depressed patient Barbara SAHAKIAN (United Kingdom) |
| 10.00-10.30 | SO 0803 Review of current evidence for treatment of cognitive dysfunction of depression Siegfried KASPER (Austria) |
| Symposium sponsored by an unrestricted educational grant from H. Lundbeck A/S | |
| 10.30-11.00 | Coffee break |
| 11.00-12.30 | SO 09 DEVELOPMENTS IN THE TREATMENT OF ANXIETY DISORDERS |
| 11.00-11.25 | SO 0901 Sexual Disorders and OCD Jose MENCHON (Spain) |
| 11.25-11.50 | SO 0902 Is hoarding a separate disorder? Stefano PALLANTI (Italy) |
| 11.50-12.15 | SO 0903 Long term treatment of anxiety disordersand OCD David BALDWIN (United Kingdom) |
| 12.15-12.30 | Discussion |
| 12.30-13.30 | Lunch |
| 13.30-15.00 | SO 10 NEW TARGETS FOR DEPRESSION |
| 13.30-13.55 | SO 1001 Are there new potential targets for depression? Torgny SVENSSON (Sweden) |
| 13.55-14.20 | SO 1002 Neuroinflammation in MDD: current status and treatment options Johan den BOER (The Netherlands) |
| 14.20-14.45 | SO 1003 Cardiovascular outcome in MDD Timothy DINAN (Ireland) |
| 14.45-15.00 | Discussion |
| 15.00-16.30 | SO 11 POETRY AND THE MEASUREMENT OF DEPRESSION – A PERSONAL JOURNEY Siegfried KASPER (Austria) Stuart MONTGOMERY (United Kingdom) |
Symposium sponsored by an unrestricted
educational grant from H. Lundbeck A/S